G6PC1
G6PC1 (glucose-6-phosphatase catalytic subunit 1, also known as G6PC, G6PT or GSD1a) is an endoplasmic reticulum enzyme that hydrolyses glucose-6-phosphate to glucose. It is the key enzyme in the homeostatic regulation of blood glucose levels. Browse Assay Genie's current range of G6PC1 research reagents below, or read on for the biology behind the target.
G6PC1 catalyses the hydrolysis of D-glucose 6-phosphate to D-glucose and orthophosphate in the endoplasmic reticulum. Together with the glucose-6-phosphate transporter (SLC37A4, also called G6PT), it forms the complex responsible for glucose production in the terminal step of both glycogenolysis and gluconeogenesis. This places the enzyme at the centre of homeostatic control of blood glucose levels.
Glucose-6-phosphatase (G6Pase) is a multi-subunit integral membrane protein of the endoplasmic reticulum. It is composed of a catalytic subunit and transporters for glucose-6-phosphate, inorganic phosphate and glucose. The G6PC1 protein is the catalytic subunit and belongs to the glucose-6-phosphatase family. In humans, the G6PC1 gene is one of three genes encoding glucose-6-phosphatase catalytic subunits, the others being G6PC2 and G6PC3. HGNC places it in the gene group of catalytic glucose 6-phosphatases. Mouse and rat orthologs are both named G6pc1.
The gene has carried several names, including G6PC and the earlier descriptive name glucose-6-phosphatase, catalytic (glycogen storage disease type I, von Gierke disease). Mutations in the G6PC1 gene cause glycogen storage disease type I (GSD1, also called GSD1a or von Gierke disease). This metabolic disorder is characterised by severe hypoglycaemia together with accumulation of glycogen and fat in the liver and kidneys, which makes G6PC1 a frequent subject in studies of glucose metabolism and inherited metabolic disease.
G6PC1 is the key enzyme in homeostatic regulation of blood glucose levels, making it central to studies of glucose production.
Together with SLC37A4, G6PC1 carries out the terminal step of both pathways, releasing free glucose from glucose-6-phosphate.
Mutations in the G6PC1 gene cause GSD1 (von Gierke disease), a disorder marked by severe hypoglycaemia and glycogen and fat accumulation.
As an integral ER membrane enzyme working with glucose-6-phosphate, phosphate and glucose transporters, G6PC1 is a model for membrane-bound phosphatase studies.
G6PC1 hydrolyses glucose-6-phosphate to glucose in the endoplasmic reticulum. With the glucose-6-phosphate transporter SLC37A4 (G6PT), it forms the complex that produces glucose in the final step of glycogenolysis and gluconeogenesis, so it is the key enzyme regulating blood glucose homeostasis.
G6PC and GSD1a are listed as aliases or previous symbols of the G6PC1 gene. G6PT is also listed as an alias, although in UniProt G6PT is the name given to SLC37A4, the glucose-6-phosphate transporter that works with G6PC1. Check the datasheet of any product for its validated reactivity.
Mutations in the G6PC1 gene cause glycogen storage disease type I (von Gierke disease), a metabolic disorder with severe hypoglycaemia and glycogen and fat accumulation in liver and kidneys. Mouse and rat orthologs are both called G6pc1. Check the datasheet of any product for its validated reactivity.
Other glucose-6-phosphatase catalytic subunits and the glucose-6-phosphate transporter involved in glucose homeostasis.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P35575; product specifications from Assay Genie datasheets.